| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |